Crossmark

Proteomic aptamer analysis reveals serum markers that characterize preclinical systemic sclerosis (SSc) patients at risk for progression toward definite SSc

Crossref DOI link: https://doi.org/10.1186/s13075-023-02989-w

Published Online: 2023-01-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bellocchi, Chiara

Assassi, Shervin

Lyons, Marka

Marchini, Maurizio

Mohan, Chandra

Santaniello, Alessandro

Beretta, Lorenzo
License Information

Text and Data Mining valid from 2023-01-27

Version of Record valid from 2023-01-27
More Information

Article History

Received: 11 September 2022

Accepted: 4 January 2023

First Online: 27 January 2023

Declarations

:

: The present study involved human participants and was reviewed and approved by Comitato Etico Milano Area 2. The patients/participants provided their written informed consent to participate in this study.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below